هدکشنادهدکشناد سوريو هورگ · versant hbv dna 3.0 (bdna) (bayer diagnostics)...
TRANSCRIPT
![Page 1: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/1.jpg)
زا دکتر سيد محمد جزايریکتB آزمايشگاه ھپاتيت
شناسی ويروس بھداشت- گروه دانشکده دانشکده بھداشت- گروه ويروس شناسیدانشگاه علوم پزشکی تھران
١٣٩٢- کنگره ارتقا کيفيت
![Page 2: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/2.jpg)
HBV PUBLIC HEALTH IMPLICATIONSIMPLICATIONS
2 billion people have been infected by HBV worldwide.ll ff f h f f350‐400 million suffer from chronic HBV infection of
whom 25% will die of chronic liver disease or HCC.HCC and liver failure are the main cause of death and HCC and liver failure are the main cause of death and currently over 500,000 people die each year from the consequences of HBV infection (52,000 from acute and q 5470,000 from cirrhosis or liver cancer).The World Health Organization places hepatitis B virus ( )(HBV) in the top 10 causes of death worldwide.
![Page 3: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/3.jpg)
HBV Genomic Structure
![Page 4: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/4.jpg)
Proposed Model of Major Hydrophilic Region (MHR). Jazayeri et al, 2012
![Page 5: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/5.jpg)
Serologygy
Serology tests are easy to use, inexpensive, d h b f land are the best tests for initial screening.
Despite the increase sensitivity of serologic Despite the increase sensitivity of serologic tests, a residual risk of viral hepatitis transmission still existstransmission still exists.HBsAg becomes detectable in acute infection when HBV DNA reaches a concentration above approximately 2000 pp ycopies per ml.
![Page 6: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/6.jpg)
HBsAg False Negativity
HBsAg may not be detected under the following circumstances:circumstances:
1. Window period (in the post acute phase when HBs antigen declines or immune complexes are present)antigen declines or immune complexes are present)
2. Low‐level carrier3 Resolving infection (under the detection limit of the 3. Resolving infection (under the detection limit of the
assay in chronic infection who eliminate HBsAg for many years).y y )
4. S gene mutants5. HBV with HDV/HCV/HIV co‐infection.5 / /
![Page 7: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/7.jpg)
Quantitative Assays
Several techniques for viral hepatitis quantification are employed such as: quantification are employed such as:
Si l lifi tiSignal amplification
T lifi iTarget amplification
![Page 8: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/8.jpg)
Target amplification Techniques
1. PCR (standard/conventional)2. Real Time PCR
Quantitative PCR 1. COBAS Amplicor ® (ROCHE)1. COBAS Amplicor (ROCHE)2. Superquant ® (National Genetics Ins)3 Target Capture ® (ABI)3. Target Capture (ABI)
Transcription‐mediated amplification (TMA)Nucleic Acid Sequence Based Amplification (NASBA)Nucleic Acid Sequence‐Based Amplification (NASBA)NucliSens ® (BioMerieux)
![Page 9: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/9.jpg)
A hi h d f t ti ith i i i d Real Time PCR Advantages
A high degree of automation with minimized hands‐on time and minimized risk of cross
t i ticontamination.No post‐PCR stepsRapid detectionBroad dynamic range (10 ‐ 1010 copies)y g pMultiplex approach possibleHigh precisionHigh precisionHigh technical sensitivity Th iti it f l ti PCR i / l‐The sensitivity of real time PCR is 5‐10 copy/ml.Reproducibility (CV < 2.0 %)
![Page 10: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/10.jpg)
Measurement of viral load
Indicator of disease activityy
Quantification of antiviral efficacyy
Early detection of resistant virus
Dynamics on therapy may be predictor of outcome
O l HBV & HCVOccult HBV & HCV
![Page 11: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/11.jpg)
Correlation between HBV DNA levels, serologyand histology during chronic HBV infection
HBsAg+
HBeAg + HBeAg -/Anti-HBe+
HBV DNA1010-1012 >105 <105
>105
1010-1012 >105
ALT, Histology
IMMUNOTOLERANT IMMUNOACTIVE IN-ACTIVE CARRIER REACTIVATIONPHASE PHASE (HBsAg-/ANTI-HBs+)
![Page 12: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/12.jpg)
Comparison between different HBV viral load quantitation assaysComparison between different HBV viral load quantitation assays
Assay Method Sensitivity
Digene hybrid-capture II ultra sensitive (Digene corp)
Hybrid capture signal amplification 4700 copies/ml
Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics)
Semi-automated bDNAsignal amplification 2000 copies/ml
Cobas amplicor HBV monitor (Roche molecular systems)
Semi-automated quantitative RT-PCR 200 copies/ml
Cobas TaqMan 48 HBV (Roche molecular systems) Real time PCR <50 copies/ml
Real art HBV PCR assay (Artus-Biotech) Real time PCR <50 copies/ml
![Page 13: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/13.jpg)
Quantitation assays ProblemsQuantitation assays Problems
Generating divergent results.Need for standardization of assays for the detection of viral hepatitisthe detection of viral hepatitis.
![Page 14: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/14.jpg)
HBV SeroconstellationCase report (1)
![Page 15: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/15.jpg)
Aim of StudyAim of Study
To explore the unusual serologic clinical features in chronic HBV clinical features in chronic HBV patients by applying highly sensitive molecular tests.
![Page 16: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/16.jpg)
MethodologyMethodology5 HBsAg‐negative chronic carriers with 5 g gvarious serologic pictures were enrolled in the study the study. All patients were negative for antibodies
i h i i C h i i D d h against hepatitis C, hepatitis D and human immunodeficiency virus. None had prior anti‐HBV therapy.
![Page 17: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/17.jpg)
MethodologyMethodology
HBV DNA was extracted using Qiagen Mini g Q gBlood Kit.
HBV DNA was determined in all samples by real time PCR .
The positive samples were selected for standard PCR reactionsPCR reactions.
Direct sequencing of surface genes was carried Direct sequencing of surface genes was carried out by an automated sequencer.
![Page 18: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/18.jpg)
R lt (1)Results (1)
5La
dder Pos
Neg 4 3 2 1
![Page 19: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/19.jpg)
Results (2)Results (2)
Samples (Cases) Surface Antigen Mutation(s)
1 Q129R, P153T
2 Y134H S136F2 Y134H, S136F
3 Outside of “a” determinant (S193L,Y205F,S207T,L209V,S210R,P211H)
4 R122F T125I A128L 4 R122F,T125I,A128L
5 Y134H, S136F
![Page 20: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/20.jpg)
HBV SeroconstellationHBV SeroconstellationCase report (2)Case report (2)
prevalence of occult hepatitis B virus infection in children
born to HBsAg-positive mothers g p
despite prophylaxis with hepatitis
B i ti d HBIGB vaccination and HBIG
![Page 21: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/21.jpg)
![Page 22: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/22.jpg)
OBI Definition
Occult Hepatitis B infection is defined as: “Detectable HBV DNA Among Patients“Detectable HBV DNA Among Patients Negative For HBsAg”.Occult HBV infection had not been well studied until HBV polymerase chain reaction s ud ed u V po y e se c e c o(PCR) became available.
![Page 23: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/23.jpg)
A schematic phylogenetic tree showing the association of occult hepatitis B in different clinical settings. The length of each
branch symbolizes the weight of published papers for those settings. Jazayeri et al, 2012.
![Page 24: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/24.jpg)
Aim of Study
The aim of this study was to :The aim of this study was to :1. To find out the prevalence of OBI in children
born to HBsAg carriersborn to HBsAg carriers.2. To analyze variations in the HBV genomic
h i h l l i b k h h sequence that might play a role in breakthrough HBV infection despite Immunoprophylaxis.
![Page 25: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/25.jpg)
MethodologyMethodology75 children born to HBsAg‐positive mothers who subsequently were immunized against HBV using a dose of HBIG and three standard injections of vaccine at zero, one and six months intervals were traced.
![Page 26: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/26.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
![Page 27: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/27.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
![Page 28: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/28.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
![Page 29: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/29.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
![Page 30: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/30.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
StandardPCR
![Page 31: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/31.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
Gunther MethodologyStandard
PCR
gy
![Page 32: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/32.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
Gunther MethodologyStandard
PCR
gy
Sequencing
![Page 33: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/33.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
Gunther MethodologygyStandard
PCR
Sequencing
![Page 34: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/34.jpg)
Children Immunized by HBV Vaccine & HBIG
HBsAgNegative
HBsAgTest
Real Time PCR
OBI
Gunther MethodologygyStandard
PCR
Sequencing
Mutational Analysis
![Page 35: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/35.jpg)
Real Time PCR Resultsno.Real-Time PCR
28%
Pos
72%
PosNeg
R l Ti PCR (T M ) i i i 21Real Time PCR (TaqMan) was positive in 21 (28%), all were below 104 copy/mL.
![Page 36: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/36.jpg)
Demographic, serologic and virologic data of occult HB‐positive patients.Sample Code Ageα Sex* Anti‐HBc Anti‐HBs Titer(mIU/mL) HBV DNA (copy/mL)
14 16 2 + >100 210040 15 1 ‐ 30 200042 61 1 ‐ 28 554 5546 128 1 ‐ 18 7752 17 2 ‐ >100 127056 18 1 ‐ >100 816 865 32 1 ‐ 95 380067 38 2 ‐ 38 41572 37 1 ‐ >100 22384 57 1 ‐ 36 924086 63 2 ‐ >100 474103 12 1 ‐ >100 468106 66 2 ‐ >100 1920108 35 2 ‐ >100 347108 35 2 ‐ >100 347110 10 1 + >100 500
112 22 1 ‐ 47 450
115 10 1 + 38 1200116 64 2 ‐ 25 4560616 23 1 ‐ 47 2330122 12 2 + >100 2300125 72 2 + 94 395
![Page 37: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/37.jpg)
Results of Conventional PCR
• All Real Time Positive samples were confirmed by standard PCRs at least for one site of HBV genome. Th t ifi i d i th d th S• The most specific region used in our method was the pre-S gene.
• Overall, four (19%) samples were positive for all five regions (full genome), seven (33%) for three regions, one (5%) for two regions and eight (38%) for one region
![Page 38: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/38.jpg)
Direct Sequencing Results of HBV surface Protein obtained from Occult-Infected Children
“a” determinant
Mutations Causing Undetectability of sera by Serology
![Page 39: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/39.jpg)
Amino acid changes in different proteins of HBV in OBI‐positive cases.cases.
![Page 40: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/40.jpg)
Results of Mutational Analysis
Altogether 13 patients had at least one amino Altogether, 13 patients had at least one amino acid mutation within different HBV genome interfere in either functional and/or immune interfere in either functional and/or immune epitope activity.Eight OBI positive cases did not have any Eight OBI‐positive cases did not have any mutations at all.
![Page 41: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/41.jpg)
Conclusion
S di d tSerodiscordant cases
Mutation within the “a” determinant displayed Mutation within the a determinant displayed altered binding to antibodies and cannot be detected by diagnostic assays detected by diagnostic assays.
As point amino acid mutations have been pobserved in our cases, we believe that these are escape mutants. p
The use of sensitive molecular tests such as real‐i PCR ld b h l f l i l i h time PCR would be helpful in solving these problems.
![Page 42: هدکشنادهدکشناد سوريو هورگ · Versant HBV DNA 3.0 (bDNA) (Bayer Diagnostics) Semi-automated bDNA signal amplification 2000 copies/ml Cobas amplicor HBV monitor](https://reader034.vdocuments.site/reader034/viewer/2022052100/6039c3eebde3f34b3e2ad66a/html5/thumbnails/42.jpg)